Regulation 134 Amendment to Schedule 1I1
United Kingdom
In Schedule 1 (further provisions for classification of medicinal products)f1—
(a)
in paragraph 1—
(i)
in sub-paragraph (e)(i), omit “, EU marketing authorisation”;
(ii)
in sub-paragraph (f)(i), omit “, EU marketing authorisation”;
(iii)
in sub-paragraph (g)(i), omit “, EU marketing authorisation”;
(b)
in paragraph 4, omit “, EU marketing authorisation”.
Annotations
Commencement
Footnotes
- f1
-
Relevant amendments were made to Schedule 1 by S.I. 2019/775 as amended by S.I. 2020/1488.